![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Global X China Biotech Innovations ETF | NASDAQ:CHB | NASDAQ | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.64 | 2.67 | 10.66 | 0 | 00:00:00 |
RNS Number:7602N UBS AG (EMM) 21 July 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EMM UBS AG Date of disclosure 21-Jul-2003 Contact Name Brenton Amedee Telephone number 0207 568 4981 Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies: BRITISH BIOTECH CHUBB DEBENHAMS WPP GROUP AMENDMENT If the attached Rule 38.5 disclosure is to amend a previous disclosure, please state which element(s) of previous disclosure was incorrect: In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the nature of the dealings can be fully understood. For options this should include the number of securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or received. For derivatives this should include, at least, the number of reference securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference price.For full details of disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring Section of the Panel, Tel No: 020-7638 0129. 1 FORM 38.5 CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in BRITISH BIOTECH Class of securities ORD 5P Date of disclosure 21-Jul-2003 Date of dealing 18-Jul-2003 Name of EMM UBS AG Name of offeree / offeror with whom connected Vernalis Total Number of securities bought 50,000 Highest price paid* 0.6971 GBP Lowest price paid* 0.6971 GBP Total Number of securities sold 0 Highest price received* 0.0000 GBP Lowest price received* 0.0000 GBP FORM 38.5 CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in CHUBB Class of securities ORD GBP0.36 Date of disclosure 21-Jul-2003 Date of dealing 18-Jul-2003 Name of EMM UBS AG Name of offeree / offeror with whom connected Adviser to United Technologies Corporation Total Number of securities bought 0 Highest price paid* 0.0000 GBP Lowest price paid* 0.0000 GBP Total Number of securities sold 3,294 Highest price received* 0.7575 GBP Lowest price received* 0.7575 GBP FORM 38.5 CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in DEBENHAMS Class of securities ORD GBP0.10 Date of disclosure 21-Jul-2003 Date of dealing 18-Jul-2003 Name of EMM UBS AG Name of offeree / offeror with whom connected Permira Total Number of securities bought 289,420 Highest price paid* 4.1900 GBP Lowest price paid* 4.1750 GBP Total Number of securities sold 312,699 Highest price received* 4.1862 GBP Lowest price received* 4.1799 GBP FORM 38.5 CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in WPP GROUP Class of securities ORD GBP0.10 Date of disclosure 21-Jul-2003 Date of dealing 18-Jul-2003 Name of EMM UBS AG Name of offeree / offeror with whom connected Cordiant Communications Group Plc Total Number of securities bought 203,246 Highest price paid* 5.1700 GBP Lowest price paid* 5.0925 GBP Total Number of securities sold 167,884 Highest price received* 5.1850 GBP Lowest price received* 5.1039 GBP FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EMM UBS AG Date of disclosure 21-Jul-2003 Contact Name Brenton Amedee Telephone number 0207 568 4981 Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies: WPP GROUP AMENDMENT If the attached Rule 38.5 disclosure is to amend a previous disclosure, please state which element(s) of previous disclosure was incorrect: In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the nature of the dealings can be fully understood. For options this should include the number of securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or received. For derivatives this should include, at least, the number of reference securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference price.For full details of disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring Section of the Panel, Tel No: 020-7638 0129. 2 FORM 38.5 CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in WPP GROUP Class of securities SPNS ADR-EACH REPR 5 ORD 10P Date of disclosure 21-Jul-2003 Date of dealing 18-Jul-2003 Name of EMM UBS AG Name of offeree / offeror with whom connected Total Number of securities bought 8,337 Highest price paid* 41.5080 USD Lowest price paid* 41.5080 USD Total Number of securities sold 5,558 Highest price received* 41.5080 USD Lowest price received* 0.0000 USD This information is provided by RNS The company news service from the London Stock Exchange END EMMBGGDRUSDGGXB
1 Year Global X China Biotech I... Chart |
1 Month Global X China Biotech I... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions